Evidence map›Paper›PMID 35173914›Full record

ArticleBasic and clinical neuroscience

Neuroscience-Informed Psychoeducation for Recovery: A Program to Promote Metacognition in People With Substance Use Disorders.

Tara Rezapour, Mohammad Barzegari, Elham Sharifi, Nastaran Malmir, Hamidreza Ghiasvand, Mohammad Salehi, Alireza Noroozi, Hamed Ekhtiari

Open access · diamondAbstract read
In one paragraph

Article in Basic and clinical neuroscience. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Amplifying School Mental Health Literacy Through Neuroscience Education.Behavioral sciences (Basel, Switzerland) · 2024
    Review
  5. Article
  6. Neuroscience education for people living with addiction.Journal of psychiatry & neuroscience : JPN
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Tara RezapourDepartment of Cognitive Psychology, Institute for Cognitive Science Studies (ICSS), Tehran, Iran.ORCID https://orcid.org/0000-0002-8073-7648
Mohammad BarzegariDepartment of Psychology, Faculty of Education and Psychology, Shahid Beheshti University, Tehran, Iran.ORCID https://orcid.org/0000-0002-1522-7959
Elham SharifiDepartment of Sociology, Faculty of Social Science, University of Tehran, Tehran, Iran.ORCID https://orcid.org/0000-0001-9562-557X
Nastaran MalmirIranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0003-2906-1336
Hamidreza GhiasvandDepartment of Educational Psychology, Faculty of Social Science, Islamic Azad University, Saveh, Iran.
Mohammad SalehiIranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0001-7459-9472
Alireza NorooziIranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0002-5838-4348
Hamed EkhtiariIranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0001-6902-8798
Tehran University of Medical Sciences · IRInstitute for Cognitive Science Studies · IRShahid Beheshti University · IRUniversity of Tehran · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionA brief neuroscience-informed psychoeducation program (Neuroscience-Informed Psychoeducation for Recovery [NIPER]) was developed to promote awareness (metacognition) in the main cognitive domains affected by drug and alcohol use to increase willingness to invest time and effort in the brain and cognition recovery process. The primary aim of this pilot study was to determine the feasibility and acceptability of the NIPER program and its potential effectiveness in increasing metacognition, psychological wellbeing, and willingness for the brain and cognition recovery programs among patients with Substance Use Disorders (SUDs).

methodsA total of 56 patients with SUDs were recruited from four outpatient treatment centers in Tehran City, Iran. They participated in four 90-min weekly sessions delivered adjunct to their routine treatment. The program's effectiveness was measured in terms of metacognition and psychological wellbeing at baseline and the end of the program. The rate of adherence and participation and willingness to continue with brain and cognition recovery programs were measured as feasibility outcomes.

resultsA total of 51 participants completed the study. Compared to the baseline assessments, patients reported more problems in dimensions of attention, memory, inhibitory control, decision making, motor/speech, interoception, insight, and a higher level of psychological wellbeing (t=4.66; P<0.001). In terms of feasibility outcomes, the adherence and participation rates were found above 85%. Most participants expressed their high willingness to continue the brain and cognition recovery programs (86.2%) and would introduce NIPER to their peers (98%).

conclusionConsidering the pilot results in terms of feasibility and preliminary effectiveness of NIPER in the clinical context of addiction treatment, we think that NIPER is a potentially beneficial intervention to be offered to people with SUD. It would increase their awareness and engage them in the brain and cognition recovery process. However, the clinical efficacy of the intervention should be tested in future randomized clinical trials.

Indexed as

AwarenessMetacognitionNeurosciencePsychoeducationSubstance use disorders

Identifiers

PMID35173914
PMCPMC8818120
OpenAlexW3175811561

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.